Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Delasalle

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Hematology (Amsterdam, Netherlands)|April 29, 2010
Rapid control of previously untreated multiple myeloma with bortezomib-lenalidomide-dexamethasone (BLD)M Wang, K Delasalle, S Giralt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Consolidation therapy of multiple myeloma with thalidomide-dexamethasone after intensive chemotherapyR Alexanian, D Weber, S Giralt, et al.
Hematology/Oncology Clinics of North America|April 1, 1992
Solitary plasmacytoma of bone and asymptomatic multiple myelomaM A Dimopoulos, A Moulopoulos, K Delasalle, et al.
Blood|August 15, 1992
Primary dexamethasone treatment of multiple myelomaR Alexanian, M A Dimopoulos, K Delasalle, et al.
Seminars in Oncology|April 30, 2003
Asymptomatic Waldenstrom's macroglobulinemiaR Alexanian, D Weber, K Delasalle, et al.
Hematology (Amsterdam, Netherlands)|June 15, 2007
Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myelomaM Wang, S Giralt, K Delasalle, et al.
Blood|January 15, 1994
Limited value of myeloablative therapy for late multiple myelomaR Alexanian, M Dimopoulos, T Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
Curability of solitary bone plasmacytomaM A Dimopoulos, J Goldstein, L Fuller, et al.
American Journal of Hematology|November 14, 2000
Randomized trial of alpha-interferon or dexamethasone as maintenance treatment for multiple myelomaR Alexanian, D Weber, M Dimopoulos, et al.
Blood|December 15, 1994
Early myeloablative therapy for multiple myelomaR Alexanian, M A Dimopoulos, J Hester, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Hematology (Amsterdam, Netherlands)|April 29, 2010
Rapid control of previously untreated multiple myeloma with bortezomib-lenalidomide-dexamethasone (BLD)M Wang, K Delasalle, S Giralt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Consolidation therapy of multiple myeloma with thalidomide-dexamethasone after intensive chemotherapyR Alexanian, D Weber, S Giralt, et al.
Hematology/Oncology Clinics of North America|April 1, 1992
Solitary plasmacytoma of bone and asymptomatic multiple myelomaM A Dimopoulos, A Moulopoulos, K Delasalle, et al.
Blood|August 15, 1992
Primary dexamethasone treatment of multiple myelomaR Alexanian, M A Dimopoulos, K Delasalle, et al.
Seminars in Oncology|April 30, 2003
Asymptomatic Waldenstrom's macroglobulinemiaR Alexanian, D Weber, K Delasalle, et al.
Hematology (Amsterdam, Netherlands)|June 15, 2007
Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myelomaM Wang, S Giralt, K Delasalle, et al.
Blood|January 15, 1994
Limited value of myeloablative therapy for late multiple myelomaR Alexanian, M Dimopoulos, T Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
Curability of solitary bone plasmacytomaM A Dimopoulos, J Goldstein, L Fuller, et al.
American Journal of Hematology|November 14, 2000
Randomized trial of alpha-interferon or dexamethasone as maintenance treatment for multiple myelomaR Alexanian, D Weber, M Dimopoulos, et al.
Blood|December 15, 1994
Early myeloablative therapy for multiple myelomaR Alexanian, M A Dimopoulos, J Hester, et al.
Pageof 3